nodes	percent_of_prediction	percent_of_DWPC	metapath
Medroxyprogesterone Acetate—AR—duct of salivary gland—head and neck cancer	0.0618	0.375	CbGeAlD
Medroxyprogesterone Acetate—CYP2C8—Fluorouracil—head and neck cancer	0.0295	0.42	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Fluorouracil—head and neck cancer	0.0206	0.293	CbGbCtD
Medroxyprogesterone Acetate—AKR1C3—Vincristine—Vinblastine—head and neck cancer	0.0159	1	CbGdCrCtD
Medroxyprogesterone Acetate—HSD3B2—saliva-secreting gland—head and neck cancer	0.012	0.073	CbGeAlD
Medroxyprogesterone Acetate—CYP3A4—Vinblastine—head and neck cancer	0.0111	0.158	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Docetaxel—head and neck cancer	0.00913	0.13	CbGbCtD
Medroxyprogesterone Acetate—HSD3B2—head—head and neck cancer	0.00652	0.0395	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—parotid gland—head and neck cancer	0.00531	0.0322	CbGeAlD
Medroxyprogesterone Acetate—SHBG—neck—head and neck cancer	0.0049	0.0297	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—lymph node—head and neck cancer	0.00457	0.0277	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—trachea—head and neck cancer	0.00392	0.0238	CbGeAlD
Medroxyprogesterone Acetate—SHBG—connective tissue—head and neck cancer	0.00351	0.0213	CbGeAlD
Medroxyprogesterone Acetate—ESR1—neck—head and neck cancer	0.00345	0.0209	CbGeAlD
Medroxyprogesterone Acetate—PGR—connective tissue—head and neck cancer	0.00316	0.0192	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—thyroid gland—head and neck cancer	0.0031	0.0188	CbGeAlD
Medroxyprogesterone Acetate—PGR—epithelium—head and neck cancer	0.003	0.0182	CbGeAlD
Medroxyprogesterone Acetate—Dysarthria—Fluorouracil—head and neck cancer	0.00258	0.00559	CcSEcCtD
Medroxyprogesterone Acetate—Heartburn—Docetaxel—head and neck cancer	0.00256	0.00555	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—neck—head and neck cancer	0.00255	0.0154	CbGeAlD
Medroxyprogesterone Acetate—AR—connective tissue—head and neck cancer	0.00252	0.0153	CbGeAlD
Medroxyprogesterone Acetate—ESR1—connective tissue—head and neck cancer	0.00247	0.015	CbGeAlD
Medroxyprogesterone Acetate—AR—epithelium—head and neck cancer	0.00239	0.0145	CbGeAlD
Medroxyprogesterone Acetate—Face oedema—Hydroxyurea—head and neck cancer	0.00237	0.00515	CcSEcCtD
Medroxyprogesterone Acetate—Neuritis—Docetaxel—head and neck cancer	0.00236	0.00512	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—epithelium—head and neck cancer	0.00235	0.0142	CbGeAlD
Medroxyprogesterone Acetate—SHBG—thyroid gland—head and neck cancer	0.00233	0.0141	CbGeAlD
Medroxyprogesterone Acetate—PGR—lymphoid tissue—head and neck cancer	0.00231	0.014	CbGeAlD
Medroxyprogesterone Acetate—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.0023	0.005	CcSEcCtD
Medroxyprogesterone Acetate—Necrosis—Docetaxel—head and neck cancer	0.00224	0.00487	CcSEcCtD
Medroxyprogesterone Acetate—Breast disorder—Hydroxyurea—head and neck cancer	0.00222	0.00482	CcSEcCtD
Medroxyprogesterone Acetate—Sepsis—Fluorouracil—head and neck cancer	0.00211	0.00459	CcSEcCtD
Medroxyprogesterone Acetate—PGR—thyroid gland—head and neck cancer	0.0021	0.0127	CbGeAlD
Medroxyprogesterone Acetate—Euphoric mood—Fluorouracil—head and neck cancer	0.00209	0.00455	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—parotid gland—head and neck cancer	0.00207	0.0126	CbGeAlD
Medroxyprogesterone Acetate—Depression—Vinblastine—head and neck cancer	0.00207	0.0045	CcSEcCtD
Medroxyprogesterone Acetate—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00205	0.00445	CcSEcCtD
Medroxyprogesterone Acetate—Thrombophlebitis—Fluorouracil—head and neck cancer	0.00204	0.00444	CcSEcCtD
Medroxyprogesterone Acetate—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00204	0.00442	CcSEcCtD
Medroxyprogesterone Acetate—Myocardial infarction—Vinblastine—head and neck cancer	0.00204	0.00442	CcSEcCtD
Medroxyprogesterone Acetate—Swelling—Fluorouracil—head and neck cancer	0.00201	0.00435	CcSEcCtD
Medroxyprogesterone Acetate—Amenorrhoea—Docetaxel—head and neck cancer	0.002	0.00435	CcSEcCtD
Medroxyprogesterone Acetate—Dysuria—Hydroxyurea—head and neck cancer	0.00199	0.00431	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—saliva-secreting gland—head and neck cancer	0.00199	0.012	CbGeAlD
Medroxyprogesterone Acetate—Bone disorder—Docetaxel—head and neck cancer	0.00195	0.00423	CcSEcCtD
Medroxyprogesterone Acetate—Weight increased—Hydroxyurea—head and neck cancer	0.00193	0.0042	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—lymph node—head and neck cancer	0.00193	0.0117	CbGeAlD
Medroxyprogesterone Acetate—Drug interaction—Docetaxel—head and neck cancer	0.0019	0.00412	CcSEcCtD
Medroxyprogesterone Acetate—Infestation NOS—Hydroxyurea—head and neck cancer	0.00189	0.00411	CcSEcCtD
Medroxyprogesterone Acetate—Drowsiness—Hydroxyurea—head and neck cancer	0.00189	0.00411	CcSEcCtD
Medroxyprogesterone Acetate—Infestation—Hydroxyurea—head and neck cancer	0.00189	0.00411	CcSEcCtD
Medroxyprogesterone Acetate—Amnesia—Fluorouracil—head and neck cancer	0.00188	0.00409	CcSEcCtD
Medroxyprogesterone Acetate—Haemoglobin—Vinblastine—head and neck cancer	0.00187	0.00407	CcSEcCtD
Medroxyprogesterone Acetate—Haemorrhage—Vinblastine—head and neck cancer	0.00186	0.00405	CcSEcCtD
Medroxyprogesterone Acetate—PGR—head—head and neck cancer	0.00186	0.0113	CbGeAlD
Medroxyprogesterone Acetate—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00186	0.00403	CcSEcCtD
Medroxyprogesterone Acetate—Pharyngitis—Vinblastine—head and neck cancer	0.00185	0.00402	CcSEcCtD
Medroxyprogesterone Acetate—Stomatitis—Hydroxyurea—head and neck cancer	0.00185	0.00401	CcSEcCtD
Medroxyprogesterone Acetate—AR—lymphoid tissue—head and neck cancer	0.00184	0.0112	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—connective tissue—head and neck cancer	0.00182	0.0111	CbGeAlD
Medroxyprogesterone Acetate—ESR1—lymphoid tissue—head and neck cancer	0.00181	0.011	CbGeAlD
Medroxyprogesterone Acetate—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00179	0.00389	CcSEcCtD
Medroxyprogesterone Acetate—Osteoarthritis—Fluorouracil—head and neck cancer	0.00177	0.00384	CcSEcCtD
Medroxyprogesterone Acetate—Hepatocellular injury—Docetaxel—head and neck cancer	0.00176	0.00382	CcSEcCtD
Medroxyprogesterone Acetate—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.00176	0.00382	CcSEcCtD
Medroxyprogesterone Acetate—Pulmonary embolism—Docetaxel—head and neck cancer	0.00176	0.00382	CcSEcCtD
Medroxyprogesterone Acetate—Blood pressure increased—Docetaxel—head and neck cancer	0.00176	0.00382	CcSEcCtD
Medroxyprogesterone Acetate—Injection site reaction—Docetaxel—head and neck cancer	0.00175	0.0038	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—epithelium—head and neck cancer	0.00173	0.0105	CbGeAlD
Medroxyprogesterone Acetate—Haemoglobin—Hydroxyurea—head and neck cancer	0.00171	0.00371	CcSEcCtD
Medroxyprogesterone Acetate—Haemorrhage—Hydroxyurea—head and neck cancer	0.0017	0.00369	CcSEcCtD
Medroxyprogesterone Acetate—Irritability—Fluorouracil—head and neck cancer	0.00169	0.00367	CcSEcCtD
Medroxyprogesterone Acetate—AR—thyroid gland—head and neck cancer	0.00167	0.0101	CbGeAlD
Medroxyprogesterone Acetate—Fluid retention—Docetaxel—head and neck cancer	0.00167	0.00363	CcSEcCtD
Medroxyprogesterone Acetate—Ataxia—Fluorouracil—head and neck cancer	0.00166	0.00361	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Vinblastine—head and neck cancer	0.00165	0.00358	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—thyroid gland—head and neck cancer	0.00164	0.00996	CbGeAlD
Medroxyprogesterone Acetate—Dry skin—Fluorouracil—head and neck cancer	0.00162	0.00352	CcSEcCtD
Medroxyprogesterone Acetate—Neoplasm—Docetaxel—head and neck cancer	0.00159	0.00345	CcSEcCtD
Medroxyprogesterone Acetate—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00158	0.00343	CcSEcCtD
Medroxyprogesterone Acetate—Muscular weakness—Fluorouracil—head and neck cancer	0.00156	0.00339	CcSEcCtD
Medroxyprogesterone Acetate—Angiopathy—Hydroxyurea—head and neck cancer	0.00154	0.00335	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—trachea—head and neck cancer	0.00153	0.00929	CbGeAlD
Medroxyprogesterone Acetate—Dysphagia—Fluorouracil—head and neck cancer	0.00153	0.00332	CcSEcCtD
Medroxyprogesterone Acetate—Sepsis—Docetaxel—head and neck cancer	0.00153	0.00331	CcSEcCtD
Medroxyprogesterone Acetate—Chills—Hydroxyurea—head and neck cancer	0.00153	0.00331	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Vinblastine—head and neck cancer	0.00151	0.00327	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Hydroxyurea—head and neck cancer	0.0015	0.00326	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Vinblastine—head and neck cancer	0.0015	0.00326	CcSEcCtD
Medroxyprogesterone Acetate—AR—head—head and neck cancer	0.00148	0.009	CbGeAlD
Medroxyprogesterone Acetate—Erythema—Hydroxyurea—head and neck cancer	0.00148	0.00321	CcSEcCtD
Medroxyprogesterone Acetate—Thrombophlebitis—Docetaxel—head and neck cancer	0.00148	0.0032	CcSEcCtD
Medroxyprogesterone Acetate—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.00147	0.00319	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Vinblastine—head and neck cancer	0.00146	0.00318	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Vinblastine—head and neck cancer	0.00146	0.00317	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—head—head and neck cancer	0.00146	0.00883	CbGeAlD
Medroxyprogesterone Acetate—Swelling—Docetaxel—head and neck cancer	0.00145	0.00314	CcSEcCtD
Medroxyprogesterone Acetate—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00142	0.00309	CcSEcCtD
Medroxyprogesterone Acetate—Hepatic failure—Docetaxel—head and neck cancer	0.00142	0.00308	CcSEcCtD
Medroxyprogesterone Acetate—Cardiac failure congestive—Docetaxel—head and neck cancer	0.00141	0.00306	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Vinblastine—head and neck cancer	0.00141	0.00305	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00137	0.00298	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Hydroxyurea—head and neck cancer	0.00137	0.00297	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Vinblastine—head and neck cancer	0.00137	0.00296	CcSEcCtD
Medroxyprogesterone Acetate—Hot flush—Docetaxel—head and neck cancer	0.00136	0.00296	CcSEcCtD
Medroxyprogesterone Acetate—Infestation NOS—Fluorouracil—head and neck cancer	0.00136	0.00296	CcSEcCtD
Medroxyprogesterone Acetate—Infestation—Fluorouracil—head and neck cancer	0.00136	0.00296	CcSEcCtD
Medroxyprogesterone Acetate—Menopausal symptoms—Docetaxel—head and neck cancer	0.00135	0.00294	CcSEcCtD
Medroxyprogesterone Acetate—Visual disturbance—Docetaxel—head and neck cancer	0.00135	0.00293	CcSEcCtD
Medroxyprogesterone Acetate—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00134	0.00292	CcSEcCtD
Medroxyprogesterone Acetate—Myocardial infarction—Fluorouracil—head and neck cancer	0.00134	0.0029	CcSEcCtD
Medroxyprogesterone Acetate—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00134	0.0029	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Hydroxyurea—head and neck cancer	0.00133	0.0029	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—lymphoid tissue—head and neck cancer	0.00133	0.00809	CbGeAlD
Medroxyprogesterone Acetate—Stomatitis—Fluorouracil—head and neck cancer	0.00133	0.00289	CcSEcCtD
Medroxyprogesterone Acetate—Urinary tract infection—Fluorouracil—head and neck cancer	0.00133	0.00288	CcSEcCtD
Medroxyprogesterone Acetate—PGR—lymph node—head and neck cancer	0.0013	0.00791	CbGeAlD
Medroxyprogesterone Acetate—Thrombocytopenia—Vinblastine—head and neck cancer	0.0013	0.00282	CcSEcCtD
Medroxyprogesterone Acetate—Epistaxis—Fluorouracil—head and neck cancer	0.00129	0.00279	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Hydroxyurea—head and neck cancer	0.00128	0.00278	CcSEcCtD
Medroxyprogesterone Acetate—Sinusitis—Fluorouracil—head and neck cancer	0.00128	0.00278	CcSEcCtD
Medroxyprogesterone Acetate—Pain in extremity—Docetaxel—head and neck cancer	0.00128	0.00277	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Vinblastine—head and neck cancer	0.00126	0.00274	CcSEcCtD
Medroxyprogesterone Acetate—Migraine—Docetaxel—head and neck cancer	0.00126	0.00273	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00125	0.00272	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Hydroxyurea—head and neck cancer	0.00125	0.0027	CcSEcCtD
Medroxyprogesterone Acetate—Haemoglobin—Fluorouracil—head and neck cancer	0.00123	0.00267	CcSEcCtD
Medroxyprogesterone Acetate—Haemorrhage—Fluorouracil—head and neck cancer	0.00122	0.00266	CcSEcCtD
Medroxyprogesterone Acetate—Pharyngitis—Fluorouracil—head and neck cancer	0.00121	0.00264	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—thyroid gland—head and neck cancer	0.00121	0.00735	CbGeAlD
Medroxyprogesterone Acetate—Oedema—Hydroxyurea—head and neck cancer	0.00121	0.00262	CcSEcCtD
Medroxyprogesterone Acetate—Ataxia—Docetaxel—head and neck cancer	0.0012	0.00261	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Hydroxyurea—head and neck cancer	0.0012	0.00261	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Vinblastine—head and neck cancer	0.00119	0.00258	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00118	0.00257	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00118	0.00257	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Hydroxyurea—head and neck cancer	0.00117	0.00255	CcSEcCtD
Medroxyprogesterone Acetate—Dry skin—Docetaxel—head and neck cancer	0.00117	0.00254	CcSEcCtD
Medroxyprogesterone Acetate—Orthostatic hypotension—Docetaxel—head and neck cancer	0.00117	0.00253	CcSEcCtD
Medroxyprogesterone Acetate—Breast disorder—Docetaxel—head and neck cancer	0.00115	0.00251	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Hydroxyurea—head and neck cancer	0.00115	0.0025	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Vinblastine—head and neck cancer	0.00115	0.0025	CcSEcCtD
Medroxyprogesterone Acetate—Cramp muscle—Docetaxel—head and neck cancer	0.00115	0.0025	CcSEcCtD
Medroxyprogesterone Acetate—Nasopharyngitis—Docetaxel—head and neck cancer	0.00114	0.00248	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Vinblastine—head and neck cancer	0.00113	0.00246	CcSEcCtD
Medroxyprogesterone Acetate—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00113	0.00245	CcSEcCtD
Medroxyprogesterone Acetate—Dysphagia—Docetaxel—head and neck cancer	0.0011	0.0024	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Vinblastine—head and neck cancer	0.00109	0.00237	CcSEcCtD
Medroxyprogesterone Acetate—Bronchospasm—Docetaxel—head and neck cancer	0.00109	0.00236	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00108	0.00235	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Fluorouracil—head and neck cancer	0.00108	0.00235	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Hydroxyurea—head and neck cancer	0.00108	0.00234	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—head—head and neck cancer	0.00108	0.00652	CbGeAlD
Medroxyprogesterone Acetate—Somnolence—Hydroxyurea—head and neck cancer	0.00107	0.00233	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Fluorouracil—head and neck cancer	0.00107	0.00231	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Hydroxyurea—head and neck cancer	0.00106	0.00231	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Hydroxyurea—head and neck cancer	0.00105	0.00228	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Vinblastine—head and neck cancer	0.00105	0.00227	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00104	0.00226	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Hydroxyurea—head and neck cancer	0.00104	0.00226	CcSEcCtD
Medroxyprogesterone Acetate—AR—lymph node—head and neck cancer	0.00104	0.0063	CbGeAlD
Medroxyprogesterone Acetate—Constipation—Hydroxyurea—head and neck cancer	0.00103	0.00224	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—lymph node—head and neck cancer	0.00102	0.00619	CbGeAlD
Medroxyprogesterone Acetate—Weight increased—Docetaxel—head and neck cancer	0.001	0.00218	CcSEcCtD
Medroxyprogesterone Acetate—Weight decreased—Docetaxel—head and neck cancer	0.000998	0.00217	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000995	0.00216	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Fluorouracil—head and neck cancer	0.000985	0.00214	CcSEcCtD
Medroxyprogesterone Acetate—Infestation NOS—Docetaxel—head and neck cancer	0.000984	0.00214	CcSEcCtD
Medroxyprogesterone Acetate—Infestation—Docetaxel—head and neck cancer	0.000984	0.00214	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Vinblastine—head and neck cancer	0.000976	0.00212	CcSEcCtD
Medroxyprogesterone Acetate—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00097	0.00211	CcSEcCtD
Medroxyprogesterone Acetate—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000965	0.00209	CcSEcCtD
Medroxyprogesterone Acetate—Myocardial infarction—Docetaxel—head and neck cancer	0.000965	0.00209	CcSEcCtD
Medroxyprogesterone Acetate—Stomatitis—Docetaxel—head and neck cancer	0.000959	0.00208	CcSEcCtD
Medroxyprogesterone Acetate—Jaundice—Docetaxel—head and neck cancer	0.000959	0.00208	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Hydroxyurea—head and neck cancer	0.000955	0.00207	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Vinblastine—head and neck cancer	0.00095	0.00206	CcSEcCtD
Medroxyprogesterone Acetate—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000931	0.00202	CcSEcCtD
Medroxyprogesterone Acetate—Epistaxis—Docetaxel—head and neck cancer	0.000928	0.00202	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Fluorouracil—head and neck cancer	0.000923	0.002	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Fluorouracil—head and neck cancer	0.000907	0.00197	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Fluorouracil—head and neck cancer	0.000907	0.00197	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Vinblastine—head and neck cancer	0.000906	0.00197	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Fluorouracil—head and neck cancer	0.000896	0.00195	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00089	0.00193	CcSEcCtD
Medroxyprogesterone Acetate—Haemoglobin—Docetaxel—head and neck cancer	0.000888	0.00193	CcSEcCtD
Medroxyprogesterone Acetate—Hepatitis—Docetaxel—head and neck cancer	0.000883	0.00192	CcSEcCtD
Medroxyprogesterone Acetate—Haemorrhage—Docetaxel—head and neck cancer	0.000883	0.00192	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Fluorouracil—head and neck cancer	0.000877	0.0019	CcSEcCtD
Medroxyprogesterone Acetate—Pharyngitis—Docetaxel—head and neck cancer	0.000877	0.0019	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Vinblastine—head and neck cancer	0.000876	0.0019	CcSEcCtD
Medroxyprogesterone Acetate—Urinary tract disorder—Docetaxel—head and neck cancer	0.000872	0.00189	CcSEcCtD
Medroxyprogesterone Acetate—Oedema peripheral—Docetaxel—head and neck cancer	0.00087	0.00189	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00087	0.00189	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Fluorouracil—head and neck cancer	0.00087	0.00189	CcSEcCtD
Medroxyprogesterone Acetate—Connective tissue disorder—Docetaxel—head and neck cancer	0.000868	0.00188	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Hydroxyurea—head and neck cancer	0.000867	0.00188	CcSEcCtD
Medroxyprogesterone Acetate—Urethral disorder—Docetaxel—head and neck cancer	0.000866	0.00188	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Fluorouracil—head and neck cancer	0.000864	0.00188	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Fluorouracil—head and neck cancer	0.000853	0.00185	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000851	0.00185	CcSEcCtD
Medroxyprogesterone Acetate—Visual impairment—Docetaxel—head and neck cancer	0.000851	0.00185	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Fluorouracil—head and neck cancer	0.000849	0.00184	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Vinblastine—head and neck cancer	0.000842	0.00183	CcSEcCtD
Medroxyprogesterone Acetate—Erythema multiforme—Docetaxel—head and neck cancer	0.000835	0.00181	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Vinblastine—head and neck cancer	0.00083	0.0018	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Fluorouracil—head and neck cancer	0.000829	0.0018	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Hydroxyurea—head and neck cancer	0.000827	0.00179	CcSEcCtD
Medroxyprogesterone Acetate—Eye disorder—Docetaxel—head and neck cancer	0.000826	0.00179	CcSEcCtD
Medroxyprogesterone Acetate—Cardiac disorder—Docetaxel—head and neck cancer	0.00082	0.00178	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Fluorouracil—head and neck cancer	0.000813	0.00176	CcSEcCtD
Medroxyprogesterone Acetate—Angiopathy—Docetaxel—head and neck cancer	0.000801	0.00174	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Hydroxyurea—head and neck cancer	0.000799	0.00173	CcSEcCtD
Medroxyprogesterone Acetate—Immune system disorder—Docetaxel—head and neck cancer	0.000798	0.00173	CcSEcCtD
Medroxyprogesterone Acetate—Mediastinal disorder—Docetaxel—head and neck cancer	0.000796	0.00173	CcSEcCtD
Medroxyprogesterone Acetate—Chills—Docetaxel—head and neck cancer	0.000793	0.00172	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000792	0.00172	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Vinblastine—head and neck cancer	0.000787	0.00171	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Fluorouracil—head and neck cancer	0.000786	0.00171	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Fluorouracil—head and neck cancer	0.000781	0.0017	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Docetaxel—head and neck cancer	0.000781	0.00169	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Fluorouracil—head and neck cancer	0.000775	0.00168	CcSEcCtD
Medroxyprogesterone Acetate—Mental disorder—Docetaxel—head and neck cancer	0.000774	0.00168	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Fluorouracil—head and neck cancer	0.000773	0.00168	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Docetaxel—head and neck cancer	0.000769	0.00167	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Docetaxel—head and neck cancer	0.000769	0.00167	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Hydroxyurea—head and neck cancer	0.000768	0.00167	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Fluorouracil—head and neck cancer	0.000765	0.00166	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Hydroxyurea—head and neck cancer	0.000762	0.00165	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Hydroxyurea—head and neck cancer	0.000761	0.00165	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Hydroxyurea—head and neck cancer	0.000757	0.00164	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Fluorouracil—head and neck cancer	0.000756	0.00164	CcSEcCtD
Medroxyprogesterone Acetate—Dysgeusia—Docetaxel—head and neck cancer	0.000753	0.00163	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—lymph node—head and neck cancer	0.000753	0.00456	CbGeAlD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000751	0.00163	CcSEcCtD
Medroxyprogesterone Acetate—Back pain—Docetaxel—head and neck cancer	0.000744	0.00161	CcSEcCtD
Medroxyprogesterone Acetate—Muscle spasms—Docetaxel—head and neck cancer	0.000739	0.00161	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Hydroxyurea—head and neck cancer	0.000718	0.00156	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Fluorouracil—head and neck cancer	0.000717	0.00156	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Docetaxel—head and neck cancer	0.000711	0.00154	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Fluorouracil—head and neck cancer	0.000691	0.0015	CcSEcCtD
Medroxyprogesterone Acetate—Syncope—Docetaxel—head and neck cancer	0.00069	0.0015	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Fluorouracil—head and neck cancer	0.000687	0.00149	CcSEcCtD
Medroxyprogesterone Acetate—Palpitations—Docetaxel—head and neck cancer	0.00068	0.00148	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Docetaxel—head and neck cancer	0.000676	0.00147	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Docetaxel—head and neck cancer	0.000666	0.00145	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Docetaxel—head and neck cancer	0.000655	0.00142	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Docetaxel—head and neck cancer	0.000655	0.00142	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Docetaxel—head and neck cancer	0.000655	0.00142	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00065	0.00141	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Fluorouracil—head and neck cancer	0.000641	0.00139	CcSEcCtD
Medroxyprogesterone Acetate—Dry mouth—Docetaxel—head and neck cancer	0.00064	0.00139	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Docetaxel—head and neck cancer	0.000633	0.00137	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Docetaxel—head and neck cancer	0.000628	0.00136	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Docetaxel—head and neck cancer	0.000628	0.00136	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Docetaxel—head and neck cancer	0.000623	0.00135	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Docetaxel—head and neck cancer	0.000617	0.00134	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Docetaxel—head and neck cancer	0.000615	0.00134	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Fluorouracil—head and neck cancer	0.000615	0.00134	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Docetaxel—head and neck cancer	0.000614	0.00133	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Docetaxel—head and neck cancer	0.000613	0.00133	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Docetaxel—head and neck cancer	0.00061	0.00132	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Docetaxel—head and neck cancer	0.000598	0.0013	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Fluorouracil—head and neck cancer	0.000595	0.00129	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Docetaxel—head and neck cancer	0.000586	0.00127	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Fluorouracil—head and neck cancer	0.000575	0.00125	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000572	0.00124	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Docetaxel—head and neck cancer	0.000568	0.00123	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Docetaxel—head and neck cancer	0.000564	0.00122	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Docetaxel—head and neck cancer	0.00056	0.00121	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Docetaxel—head and neck cancer	0.000558	0.00121	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Fluorouracil—head and neck cancer	0.000553	0.0012	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Docetaxel—head and neck cancer	0.000552	0.0012	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Fluorouracil—head and neck cancer	0.000548	0.00119	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Fluorouracil—head and neck cancer	0.000548	0.00119	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Docetaxel—head and neck cancer	0.000546	0.00118	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Fluorouracil—head and neck cancer	0.000545	0.00118	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000542	0.00118	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Docetaxel—head and neck cancer	0.000541	0.00117	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Docetaxel—head and neck cancer	0.000537	0.00117	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Docetaxel—head and neck cancer	0.000517	0.00112	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Fluorouracil—head and neck cancer	0.000516	0.00112	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000513	0.00111	CcSEcCtD
Medroxyprogesterone Acetate—Drospirenone—PTGS2—head and neck cancer	0.000498	0.455	CrCbGaD
Medroxyprogesterone Acetate—Body temperature increased—Docetaxel—head and neck cancer	0.000496	0.00108	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Docetaxel—head and neck cancer	0.000496	0.00108	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Docetaxel—head and neck cancer	0.000462	0.001	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Docetaxel—head and neck cancer	0.00045	0.000978	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Docetaxel—head and neck cancer	0.000444	0.000964	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.000442	0.00154	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Leptin signaling pathway—MAPK3—head and neck cancer	0.000437	0.00152	CbGpPWpGaD
Medroxyprogesterone Acetate—Diarrhoea—Docetaxel—head and neck cancer	0.000429	0.000932	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000425	0.00148	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—MAPK3—head and neck cancer	0.000423	0.00147	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000421	0.00147	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Leptin signaling pathway—MAPK1—head and neck cancer	0.000416	0.00145	CbGpPWpGaD
Medroxyprogesterone Acetate—Dizziness—Docetaxel—head and neck cancer	0.000415	0.000901	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—YAP1—head and neck cancer	0.000412	0.00143	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—CASP8—head and neck cancer	0.000411	0.00143	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—CDH1—head and neck cancer	0.000406	0.00141	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—YAP1—head and neck cancer	0.000406	0.00141	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—TYMS—head and neck cancer	0.000405	0.00141	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—MAPK1—head and neck cancer	0.000402	0.0014	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—EGFR—head and neck cancer	0.000402	0.0014	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000401	0.0014	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—head and neck cancer	0.000401	0.00139	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—GSTM1—head and neck cancer	0.0004	0.00139	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—NAT2—head and neck cancer	0.0004	0.00139	CbGpPWpGaD
Medroxyprogesterone Acetate—Vomiting—Docetaxel—head and neck cancer	0.000399	0.000866	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Docetaxel—head and neck cancer	0.000396	0.000859	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Docetaxel—head and neck cancer	0.000395	0.000858	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—KISS1—head and neck cancer	0.000394	0.00137	CbGpPWpGaD
Medroxyprogesterone Acetate—Headache—Docetaxel—head and neck cancer	0.000393	0.000854	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—CCND1—head and neck cancer	0.000393	0.00137	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000384	0.00134	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—GPX1—head and neck cancer	0.000383	0.00133	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—head and neck cancer	0.000381	0.00133	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—CYP1A1—head and neck cancer	0.00038	0.00132	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.000379	0.00132	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—PTEN—head and neck cancer	0.000379	0.00132	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000379	0.00132	CbGpPWpGaD
Medroxyprogesterone Acetate—Nausea—Docetaxel—head and neck cancer	0.000373	0.000809	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Gene Expression—RARB—head and neck cancer	0.000371	0.00129	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—TP53—head and neck cancer	0.000369	0.00128	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—TP53—head and neck cancer	0.000363	0.00126	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	0.00036	0.00125	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—head and neck cancer	0.00036	0.00125	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000353	0.00123	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—BCL2—head and neck cancer	0.000353	0.00123	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—DPYD—head and neck cancer	0.000351	0.00122	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—PIK3CA—head and neck cancer	0.000349	0.00122	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000348	0.00121	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—VEGFA—head and neck cancer	0.000342	0.00119	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.00034	0.00119	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—YAP1—head and neck cancer	0.000338	0.00118	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Leptin signaling pathway—HRAS—head and neck cancer	0.000334	0.00116	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000334	0.00116	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Androgen receptor signaling pathway—AKT1—head and neck cancer	0.000334	0.00116	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—YAP1—head and neck cancer	0.000333	0.00116	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	0.000326	0.00113	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Biological oxidations—GSTM1—head and neck cancer	0.000325	0.00113	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—GRP—head and neck cancer	0.000324	0.00113	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—HRAS—head and neck cancer	0.000323	0.00112	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metapathway biotransformation—GSTM1—head and neck cancer	0.000321	0.00112	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—TP53—head and neck cancer	0.00032	0.00111	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Regulation of Telomerase—AKT1—head and neck cancer	0.000319	0.00111	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000316	0.0011	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—STAT6—head and neck cancer	0.000315	0.0011	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	0.000314	0.00109	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000312	0.00109	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000311	0.00108	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—KISS1—head and neck cancer	0.000311	0.00108	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—MAPK1—head and neck cancer	0.000308	0.00107	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—EGFR—head and neck cancer	0.000308	0.00107	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Biological oxidations—CYP1A1—head and neck cancer	0.000308	0.00107	CbGpPWpGaD
Medroxyprogesterone Acetate—Progesterone—CYP1A1—head and neck cancer	0.000307	0.28	CrCbGaD
Medroxyprogesterone Acetate—CYP2C8—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000304	0.00106	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—CCND1—head and neck cancer	0.000303	0.00105	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Leptin signaling pathway—AKT1—head and neck cancer	0.000295	0.00103	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.000292	0.00102	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—PTEN—head and neck cancer	0.000292	0.00102	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—PTEN—head and neck cancer	0.000291	0.00101	CbGpPWpGaD
Medroxyprogesterone Acetate—Testosterone—CYP1A1—head and neck cancer	0.00029	0.265	CrCbGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—STAT3—head and neck cancer	0.00029	0.00101	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—AKT1—head and neck cancer	0.000285	0.000993	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	0.000284	0.000988	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—RARB—head and neck cancer	0.000283	0.000985	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—YAP1—head and neck cancer	0.000279	0.00097	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	0.000278	0.000966	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—head and neck cancer	0.000277	0.000964	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—head and neck cancer	0.000273	0.00095	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—UROD—head and neck cancer	0.000271	0.000944	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—head and neck cancer	0.00027	0.000941	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.000268	0.000935	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	0.000265	0.000921	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—VEGFA—head and neck cancer	0.000264	0.000918	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	0.000261	0.000908	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—TP53—head and neck cancer	0.000259	0.000901	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—YAP1—head and neck cancer	0.000257	0.000896	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—GRP—head and neck cancer	0.000256	0.00089	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	0.000255	0.000889	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	0.000255	0.000889	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000253	0.000881	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	0.000251	0.000873	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	0.000251	0.000873	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.00025	0.000871	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—STAT6—head and neck cancer	0.000248	0.000864	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—MAPK3—head and neck cancer	0.000248	0.000864	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000247	0.000861	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	0.000242	0.000843	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000241	0.000839	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—MAPK1—head and neck cancer	0.000237	0.000827	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—EGFR—head and neck cancer	0.000237	0.000826	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—MAPK1—head and neck cancer	0.000236	0.000822	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—EGFR—head and neck cancer	0.000236	0.000822	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—PTGS2—head and neck cancer	0.000226	0.000786	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	0.000222	0.000772	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—UROD—head and neck cancer	0.000221	0.000768	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—YAP1—head and neck cancer	0.00022	0.000765	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	0.000219	0.000761	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—AKT1—head and neck cancer	0.000219	0.000761	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000218	0.00076	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—RARB—head and neck cancer	0.000218	0.000759	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—RARB—head and neck cancer	0.000215	0.000747	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	0.000214	0.000746	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.00021	0.000732	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.000207	0.00072	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—PIK3CA—head and neck cancer	0.000205	0.000714	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—TYMS—head and neck cancer	0.0002	0.000696	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—TP53—head and neck cancer	0.000199	0.000694	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—YAP1—head and neck cancer	0.000198	0.000691	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—GSTM1—head and neck cancer	0.000198	0.000688	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—PTEN—head and neck cancer	0.000197	0.000685	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	0.000197	0.000685	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	0.000197	0.000685	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—YAP1—head and neck cancer	0.000195	0.00068	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—HRAS—head and neck cancer	0.00019	0.00066	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—GPX1—head and neck cancer	0.000189	0.000659	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—CYP1A1—head and neck cancer	0.000187	0.000653	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000186	0.000646	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000183	0.000637	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—KISS1—head and neck cancer	0.000182	0.000635	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	0.000181	0.00063	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—NOTCH1—head and neck cancer	0.000179	0.000624	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	0.000175	0.000607	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	0.000172	0.000599	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000171	0.000596	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	0.000171	0.000594	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—AKT1—head and neck cancer	0.000168	0.000586	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—AKT1—head and neck cancer	0.000167	0.000583	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	0.000165	0.000576	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	0.000165	0.000575	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000163	0.000568	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000154	0.000536	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—NOTCH1—head and neck cancer	0.000152	0.00053	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—GRP—head and neck cancer	0.00015	0.000523	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—STAT6—head and neck cancer	0.000146	0.000507	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—UROD—head and neck cancer	0.000146	0.000507	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	0.000139	0.000486	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—PIK3CA—head and neck cancer	0.000139	0.000483	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—PTGS2—head and neck cancer	0.000133	0.000463	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—YAP1—head and neck cancer	0.000129	0.000449	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—NOTCH1—head and neck cancer	0.000126	0.000437	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.00012	0.000416	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000118	0.000412	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—PTEN—head and neck cancer	0.000116	0.000404	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—NOTCH1—head and neck cancer	0.000116	0.000404	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—AKT1—head and neck cancer	0.000113	0.000395	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—NAT2—head and neck cancer	0.000113	0.000392	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—PTGS2—head and neck cancer	0.000111	0.000388	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—STAT3—head and neck cancer	0.000104	0.000361	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—MAPK3—head and neck cancer	9.92e-05	0.000345	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—NOTCH1—head and neck cancer	9.9e-05	0.000345	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—DPYD—head and neck cancer	9.87e-05	0.000344	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	9.73e-05	0.000339	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—PTEN—head and neck cancer	9.72e-05	0.000338	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	9.63e-05	0.000335	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—MAPK1—head and neck cancer	9.44e-05	0.000329	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—EGFR—head and neck cancer	9.44e-05	0.000328	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—YAP1—head and neck cancer	9.37e-05	0.000326	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—NAT2—head and neck cancer	9.16e-05	0.000319	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—NOTCH1—head and neck cancer	8.94e-05	0.000311	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—NOTCH1—head and neck cancer	8.8e-05	0.000306	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IL2—head and neck cancer	8.64e-05	0.000301	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—MAPK3—head and neck cancer	8.43e-05	0.000293	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CCND1—head and neck cancer	8.42e-05	0.000293	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—PIK3CA—head and neck cancer	8.19e-05	0.000285	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—PTEN—head and neck cancer	8.13e-05	0.000283	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—DPYD—head and neck cancer	8.03e-05	0.00028	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—YAP1—head and neck cancer	7.62e-05	0.000265	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—HRAS—head and neck cancer	7.58e-05	0.000264	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—VEGFA—head and neck cancer	7.34e-05	0.000256	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—STAT3—head and neck cancer	7.27e-05	0.000253	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	7.04e-05	0.000245	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MAPK3—head and neck cancer	6.95e-05	0.000242	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—PIK3CA—head and neck cancer	6.86e-05	0.000239	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IL2—head and neck cancer	6.82e-05	0.000237	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—AKT1—head and neck cancer	6.69e-05	0.000233	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CCND1—head and neck cancer	6.64e-05	0.000231	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MAPK1—head and neck cancer	6.61e-05	0.00023	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—EGFR—head and neck cancer	6.61e-05	0.00023	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—MAPK3—head and neck cancer	6.42e-05	0.000224	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PTEN—head and neck cancer	6.41e-05	0.000223	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	6.14e-05	0.000214	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—NAT2—head and neck cancer	6.04e-05	0.00021	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NOTCH1—head and neck cancer	5.81e-05	0.000202	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—VEGFA—head and neck cancer	5.79e-05	0.000202	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—STAT3—head and neck cancer	5.74e-05	0.0002	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—PIK3CA—head and neck cancer	5.74e-05	0.0002	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	5.73e-05	0.000199	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—AKT1—head and neck cancer	5.68e-05	0.000198	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—TYMS—head and neck cancer	5.62e-05	0.000196	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—AKT1—head and neck cancer	5.6e-05	0.000195	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GSTM1—head and neck cancer	5.56e-05	0.000194	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TP53—head and neck cancer	5.55e-05	0.000193	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MAPK3—head and neck cancer	5.48e-05	0.000191	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GPX1—head and neck cancer	5.32e-05	0.000185	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—HRAS—head and neck cancer	5.31e-05	0.000185	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—DPYD—head and neck cancer	5.3e-05	0.000184	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CYP1A1—head and neck cancer	5.27e-05	0.000183	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MAPK1—head and neck cancer	5.21e-05	0.000181	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—EGFR—head and neck cancer	5.21e-05	0.000181	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—YAP1—head and neck cancer	5.03e-05	0.000175	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	5e-05	0.000174	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—MAPK3—head and neck cancer	4.95e-05	0.000172	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—MAPK3—head and neck cancer	4.87e-05	0.00017	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—AKT1—head and neck cancer	4.69e-05	0.000163	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—TYMS—head and neck cancer	4.58e-05	0.000159	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GSTM1—head and neck cancer	4.52e-05	0.000158	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PIK3CA—head and neck cancer	4.52e-05	0.000157	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TP53—head and neck cancer	4.38e-05	0.000152	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GPX1—head and neck cancer	4.33e-05	0.000151	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—AKT1—head and neck cancer	4.33e-05	0.000151	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.33e-05	0.000151	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CYP1A1—head and neck cancer	4.29e-05	0.000149	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—HRAS—head and neck cancer	4.19e-05	0.000146	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IL2—head and neck cancer	4e-05	0.000139	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CCND1—head and neck cancer	3.9e-05	0.000136	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PTEN—head and neck cancer	3.76e-05	0.000131	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—AKT1—head and neck cancer	3.7e-05	0.000129	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.52e-05	0.000123	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—VEGFA—head and neck cancer	3.4e-05	0.000118	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—STAT3—head and neck cancer	3.37e-05	0.000117	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—AKT1—head and neck cancer	3.34e-05	0.000116	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—AKT1—head and neck cancer	3.29e-05	0.000114	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MAPK3—head and neck cancer	3.22e-05	0.000112	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PTGS2—head and neck cancer	3.13e-05	0.000109	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MAPK1—head and neck cancer	3.06e-05	0.000107	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—EGFR—head and neck cancer	3.06e-05	0.000106	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—TYMS—head and neck cancer	3.02e-05	0.000105	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GSTM1—head and neck cancer	2.98e-05	0.000104	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GPX1—head and neck cancer	2.86e-05	9.95e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CYP1A1—head and neck cancer	2.83e-05	9.85e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PTEN—head and neck cancer	2.73e-05	9.52e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PIK3CA—head and neck cancer	2.66e-05	9.24e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TP53—head and neck cancer	2.57e-05	8.94e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PTGS2—head and neck cancer	2.55e-05	8.88e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HRAS—head and neck cancer	2.46e-05	8.55e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PTEN—head and neck cancer	2.22e-05	7.74e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—AKT1—head and neck cancer	2.17e-05	7.55e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PIK3CA—head and neck cancer	1.93e-05	6.71e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PTGS2—head and neck cancer	1.68e-05	5.86e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—AKT1—head and neck cancer	1.58e-05	5.48e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PIK3CA—head and neck cancer	1.57e-05	5.46e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PTEN—head and neck cancer	1.47e-05	5.11e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—AKT1—head and neck cancer	1.28e-05	4.46e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PIK3CA—head and neck cancer	1.04e-05	3.6e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—AKT1—head and neck cancer	8.46e-06	2.94e-05	CbGpPWpGaD
